Advertisement

Advertisement

Expert���s Corner

Advertisement

Advertisement



May
24
Today In Oncology
Risk of Breast Cancer Among Transgender People
Prostate-Only vs Whole-Pelvis Radiotherapy in Gleason Grade 5 Prostate Cancer
Factors Associated With Major Adverse Cardiovascular Events in Survivors of Colorectal Cancer
IMmotion151: First-Line Atezolizumab/Bevacizumab vs Sunitinib in Metastatic Renal Cell Carcinoma
OPTIMISMM: Addition of Pomalidomide to Bortezomib/Dexamethasone in Pretreated Relapsed or Refractory Multiple Myeloma
View More 
;
Advertisement
Most Read Stories
TRINOVA-3: Addition of Trebananib to Carboplatin/Paclitaxel as First-Line Treatment for Advanced Ovarian Cancer
ASTRO and AUA Announce Updates to Joint Clinical Guidance for Adjuvant and Salvage Radiotherapy After Prostatectomy
Long-Term Results With Local Consolidative Therapy vs Maintenance Therapy or Observation in Oligometastatic NSCLC
Addition of Tucidinostat to Exemestane in Advanced Hormone Receptor–Positive Breast Cancer
Tumor Mutational Burden as a Marker of Response to Immunotherapy in MSI-High Metastatic Colorectal Cancer
View More 
Most Viewed Videos
John G. Gribben, MD, DSc, on The Tumor Microenvironment, Prognosis, and Outcome
Edward B. Garon, MD, on Non–Small Cell Lung Cancer: CheckMate 384 Trial on Nivolumab Dosing
Sagar Lonial, MD, on Multiple Myeloma: Sequencing Therapies
William J. Gradishar, MD, on HR-Positive, HER2-Negative Advanced Breast Cancer: NCCN Guidelines Updates
Saar I. Gill, MD, PhD, on CLL: Trial Results on Anti-CD19 CAR T Cells
View More 
© 2019 HSP News Service, L.L.C.